Moderna's Stock Is Up, Preparing for Global Launch of COVID-19 Vaccine

Moderna is gearing up for the global launch of its novel coronavirus vaccine candidate. The biotech firm has raked in $1.1 billion in deposits from governments awaiting the potentially life-saving drug.